More than 55 million people are currently living with dementia. Research into possible preventatives and treatments can’t ...

A new therapy may delay Alzheimer's disease progression by years, according to a study by researchers at Texas A&M University ...

Semaglutide, the weight management drug sold as Ozempic and Wegovy, may reduce the risk of Alzheimer's disease by 40% to 70% ...

Researchers at Monash University are conducting clinical trials of a drug that promises to be a game-changer for sufferers of ...

Starting on a more gradual dosing schedule of Eli Lilly's Alzheimer's drug Kisunla cut the percentage of patients ...

The results were pretty astounding: Patients who used Ozempic had a whopping 70% lower risk of Alzheimer's than patients who ...

There is a lot of outrage that the new Alzheimer’s drug donanemab is being refused on the NHS. But there are good reasons for ...

The purchase is the latest in a slew of efforts to invest in its neuroscience portfolio as Humira faces generic competition.

The drug works by essentially forcing our cells to "spit out" dangerous protein clumps involved in Alzheimer's.

A drug used to treat glaucoma may protect against tau protein buildup in the brain, a key marker of dementias such as ...

Biogen Inc. raised its annual earnings guidance after reporting better-than-expected third-quarter sales and profit, driven ...

Opens in a new tab or window Share on X ... bepranemab missed its primary cognitive endpoint in a phase II trial of prodromal ...